Document:

Form of Escrow Agreement

 Exhibit 10.1 
 FORM OF 
 ESCROW AGREEMENT 
 THIS ESCROW AGREEMENT, dated as of [            ], 2010 (this
“Agreement”), is by and among Myriad Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Frederick E. Pierce, II, solely in his capacity as representative of the stockholders of Javelin Pharmaceuticals, Inc.
(the “Stockholder Representative”), and American Stock Transfer and Trust Company (the “Escrow Agent”). Each capitalized term used in this Agreement but not otherwise defined herein shall have the meaning ascribed
thereto in the Merger Agreement (as defined below). Parent shall provide the Escrow Agent with a true and complete copy of the Merger Agreement for its records and reference. 
 WHEREAS, Parent, MPI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger
Sub”), and Javelin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), are parties to an Agreement and Plan of Merger, dated as of December 18, 2009 (as such agreement may be subsequently amended or
modified, the “Merger Agreement”), providing for the merger of Merger Sub with and into the Company (the “Merger”); 
 WHEREAS, pursuant to the Merger Agreement, immediately following the Merger Effective Time, Parent shall issue and deposit with the Escrow Agent a number of shares of Parent Common Stock equal to
the maximum number of additional shares of Parent Common Stock that could be issued as Milestone Shares as set forth in Section 4.01(b)(ii) of the Merger Agreement (the “Escrowed Shares”), which are to be held in escrow for the
purpose of satisfying Parent’s obligation to issue additional shares of Parent Common Stock to the Company Stockholders upon the achievement of Dyloject Approval, as hereinafter provided; and 
 WHEREAS, the parties desire to set forth their understandings with regard to the escrow account established hereunder. 
 NOW, THEREFORE, in consideration of the promises and agreements of the parties contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1.
Appointment of Agent. Parent and the Stockholder Representative hereby appoint the Escrow Agent as their agent to hold in escrow, and to administer the disposition of, the Escrow Fund (as defined below) in accordance with the terms of this
Agreement, and the Escrow Agent hereby accepts such appointment. 
 2. Stockholder Representative. Pursuant to
Section 11.01 of the Merger Agreement, the Stockholder Representative has been designated to act as the representative, agent and attorney-in-fact for the Company Stockholders and their successors and assigns for all purposes under this
Agreement. The Escrow Agent is hereby relieved from any liability to any person for any acts done by the Escrow Agent in accordance with any notice, direction, consent or instruction of or from the Stockholder Representative under this Agreement,
except as set forth in Section 9(b) hereof. 

 3. Establishment of Escrow. Immediately following the Merger Effective Time,
and in accordance with the terms of the Merger Agreement, Parent shall issue and deliver the Escrowed Shares to a special escrow account established by the Escrow Agent on behalf of Parent and the Stockholder Representative for the benefit of the
Company Stockholders (the “Escrow Account”). The Escrowed Shares shall be represented by one or more stock certificates registered in the name of the Escrow Agent or its nominee. Upon receipt of certificates representing such shares
of Parent Common Stock, the Escrow Agent shall acknowledge in writing receipt of such certificates to Parent and the Stockholder Representative. Any securities of Parent issued or distributed in respect of or in exchange for any of the Escrowed
Shares, whether by way of stock dividends, stock splits or otherwise, shall be issued in the name of the Escrow Agent or its nominee, and shall be delivered to the Escrow Agent, who shall hold such securities in the Escrow Account (such securities
being considered Escrowed Shares for the purposes hereof). The Escrow Agent shall have no responsibility to monitor or compel issuance of any Escrowed Shares in its name, but shall merely hold such shares as are delivered, as provided herein. The
Escrowed Shares held in the Escrow Account, together with any further shares that may be deposited in the Escrow Account by Parent and with any cash, securities or other property deposited in the Escrow Account in accordance with Section 4(c)
hereof, less any shares released from the Escrow Account and/or cancelled, as the case may be, from time to time in accordance with Section 6 hereof, shall be referred to herein as the “Escrow Fund.” The Escrow Agent agrees to
administer the disposition of the Escrow Fund in accordance with the terms and conditions of this Agreement. The Escrow Fund shall be segregated on the books and records of the Escrow Agent from the other assets of the Escrow Agent and shall be held
by the Escrow Agent in trust for the benefit of Parent and the Company Stockholders in accordance with the terms and conditions of this Agreement. The Escrow Fund shall not be subject to any lien, attachment, trustee process or any other judicial
process of any creditor of any party hereto, and shall be held and disbursed solely for the purposes of, and in accordance with the terms and conditions of, this Agreement. 
 4. Voting and Rights of Ownership. 
 (a) The Escrowed Shares held pursuant to this Agreement will be shown as issued and outstanding on the books and records of Parent. 
 (b) Each Company Stockholder will have the right, in its sole discretion, to direct the Escrow Agent in writing as to the exercise of any
voting rights pertaining to the Escrowed Shares and the Escrow Agent shall comply with any such written instructions. In the absence of such instructions, the Escrow Agent agrees to vote the Escrowed Shares on any matter for which the Escrowed
Shares are eligible to vote such that the votes attached to the Escrowed Shares are voted in a manner consistent with and in the same proportion to the voting of all other shares of Parent Common Stock that were eligible to vote and for which votes
were cast in respect of such matter. The Escrow Agent shall have no obligation to solicit consents or proxies from the Company Stockholder for purposes of any such vote. 
 (c) Any cash dividends or other cash distribution in respect of the Escrowed Shares shall promptly be distributed to the Company Stockholders by check payable to the Company Stockholders in proportion to
the number of Escrowed Shares that would be released to the Company Stockholders if the Dyloject Approval occurred on the record date for payment

  

 2 

 
of such dividends in accordance with Schedule A hereto. Any non-cash dividend or other non-cash distribution on the Escrowed Shares shall be issued in the name of the Escrow Agent or its nominee
and deposited with the Escrow Agent to be held in escrow along with the corresponding Escrowed Shares. Any such non-cash dividend or other non-cash distribution shall be released from escrow in conjunction with the release from escrow of the
corresponding Escrowed Shares, and Parent and the Stockholder Representative shall direct the Escrow Agent to do the same in the applicable Release Notice (as defined below). In the event all or a portion of the Escrowed Shares are cancelled, any
corresponding non-cash dividends or other non-cash distributions on such Escrowed Shares not previously distributed to the Company Stockholders shall be returned to Parent. If the Escrowed Shares are reclassified, converted or changed into, or
exchanged for securities or other property (other than cash) pursuant to a merger, consolidation or other reorganization of Parent after the Merger Effective Time, then such reclassified shares or securities or other property (other than cash), as
the case may be, shall be deposited with the Escrow Agent to be held in escrow and released from escrow and/or cancelled, as the case may be, in conjunction with the terms of this Agreement at the same time and in the same respective amounts as the
related Escrowed Shares, assuming for this purpose that such reclassification, merger, consolidation or other reorganization had not been effected. 
 5. Tax Matters. 
 (a) The parties agree solely for U.S. Tax purposes and,
to the extent permitted by applicable Law, state and local Tax purposes, (i) the Escrowed Shares shall be treated as owned by the respective Company Stockholders, (ii) any dividend or other distribution on the Escrowed Shares, whether in
the form of securities or cash, and any interest and earnings from the investment and reinvestment of any distribution on the Escrowed Shares (collectively, “Escrow Earnings”) shall, as of the end of each calendar year and to the
extent required by the Internal Revenue Code, be reported as having been earned by the respective Company Stockholders, and (iii) the Escrow Agent does not have any interest in the Escrowed Shares or Escrow Earnings. In accordance with its
respective share of the Escrow Earnings, each Company Stockholder shall report on its Tax Returns and be liable for the payment of, and shall pay when due, its respective share of any Taxes on the Escrow Earnings. For Tax reporting purposes, all
Escrow Earnings in any Tax year shall be reported as allocated to the Company Stockholders in accordance with their respective ownership of Escrowed Shares until the release of the Escrowed Shares to the Company Stockholders or the cancellation of
the Escrowed Shares. The Escrow Agent shall report all Escrow Earnings on Form 1099 or other appropriate forms with respect to each calendar year during the term of this Agreement in a manner consistent with the provisions of this Section 5(a).
Unless clearly required by applicable Law, no party to this Agreement shall take any position that is inconsistent with the provisions of this Section 5(a) for any Tax purposes. 
 (b) Each Company Stockholder shall complete, sign and send to the Escrow Agent, a Form W-9, or Form W-8, as applicable, and any other forms
and documents that the Escrow Agent may reasonably request for Tax reporting purposes. Moreover, each Company Stockholder acknowledges and agrees that, in the event the Escrow Agent is required to withhold any Taxes, the Escrow Agent shall, upon
mutual direction from Parent and the Stockholder Representative, remove such portion of any distribution to such Company Stockholder as is required to be remitted to the Internal Revenue Service in compliance with the Code or to any other applicable
Taxing Authority. 
  

 3 

 6. Release/Cancellation of the Escrowed Shares. 
 (a) Immediately following the Merger Effective Time, Parent and the Stockholder Representative will agree upon and deliver Schedule A
to the Escrow Agent which shall set forth the number of shares to be released from escrow or cancelled, as the case may be, and shall be completed in accordance with the provisions of Section 4.01(b)(ii) of the Merger Agreement. 
 (b) Release. 
 (i) If Dyloject Approval occurs on or prior to June 30, 2010, Parent shall provide the Escrow Agent and Stockholder Representative with written notice signed by the Chief Executive Officer or Chief
Financial Officer of Parent (a “Release Notice”) within two (2) Business Days of the date of Dyloject Approval. The Release Notice shall: (i) specify the date of the Dyloject Approval and (ii) provide an irrevocable
direction to release the specified number of Escrowed Shares, if any, in accordance with Section 4.01(b)(ii) of the Merger Agreement to be distributed pursuant to and as set forth in Schedule A hereto, together with any dividends or
other distributions or property paid or made in respect of such Escrowed Shares, to the Company Stockholders. 
 (ii) If Dyloject Approval occurs after June 30, 2010, but on or prior to January 31, 2011, Parent shall provide the Escrow Agent and Stockholder Representative with a Release Notice within two (2) Business Days of the date of
Dyloject Approval. The Release Notice shall: (i) specify the date of the Dyloject Approval and (ii) provide an irrevocable direction to release the specified number of Escrowed Shares, if any, in accordance with Section 4.01(b)(ii) of
the Merger Agreement to be distributed pursuant to and as set forth in Schedule A hereto, together with any dividends or other distributions or property paid or made in respect of such Escrowed Shares, to the Company Stockholders. 

(iii) If Dyloject Approval occurs after January 31, 2011, but on or prior to June 30, 2011, Parent shall provide
the Escrow Agent and Stockholder Representative with a Release Notice within two (2) Business Days of the date of Dyloject Approval. The Release Notice shall: (i) specify the date of the Dyloject Approval and (ii) provide an
irrevocable direction to release the specified number of Escrowed Shares, if any, in accordance with Section 4.01(b)(ii) of the Merger Agreement to be distributed pursuant to and as set forth in Schedule A hereto, together with any
dividends or other distributions or property paid or made in respect of such Escrowed Shares, to the Company Stockholders. 
 (iv) Parent, the Stockholder Representative and the Escrow Agent acknowledge and agree that a single Release Notice covering all the Company Stockholders and their respective numbers of the Escrowed
Shares may be provided to the Escrow Agent in lieu of a separate Release Notice for each Company Stockholder. 
  

 4 

 (v) Subject to the provisions of Section 6(d) hereof, upon receipt of a
Release Notice, the Escrow Agent shall deliver to the Transfer Agent for delivery to each Company Stockholder, within five (5) Business Days, a share certificate registered in the name of the Company Stockholder evidencing the Escrowed Shares
attributable to such the Company Stockholder released from escrow in connection with such Release Notice, as well as any dividends, distributions or other property in the Escrow Fund relating thereto. Subject to the provisions of Section 6(d)
hereof, if, on a date that Escrowed Shares are to be released, the Escrow Agent holds a stock certificate or other evidence representing more Escrowed Shares than are to be released, the Escrow Agent shall promptly deliver the stock certificate or
other evidence to Parent’s transfer agent for such shares and request replacement stock certificates or other evidence in denominations necessary to allow for the delivery to the Company Stockholder of the number of Escrowed Shares so released.
Promptly after the Escrow Agent receives the replacement share certificates or other evidence, the Escrow Agent will send to the Company Stockholder the replacement share certificate or other evidence of the Escrowed Shares released. 
 (c) Cancellation. 
 (i) If Dyloject Approval does not occur on or prior to June 30, 2010, Parent shall provide the Escrow Agent and Stockholder Representative with written notice signed by the Chief Executive Officer or
Chief Financial Officer of Parent (a “Cancellation Notice”) within two (2) Business Days of such date. The Cancellation Notice shall provide an irrevocable direction to deliver to Parent (or its transfer agent) a number of
Escrowed Shares equal to the difference between the aggregate number of Escrowed Shares deliverable pursuant to Section 6(b)(i) above and the aggregate number of Escrowed Shares deliverable pursuant to Section 6(b)(ii) above in accordance
with Section 4.01(b)(ii) of the Merger Agreement, together with any dividends or other distributions or property paid or made in respect of such Escrowed Shares in the Escrow Fund relating thereto, to be cancelled or, in the case of property
other than capital stock of Parent, released to Parent. 
 (ii) If Dyloject Approval does not occur on or prior
to January 31, 2011, Parent shall provide the Escrow Agent and Stockholder Representative with a Cancellation Notice within two (2) Business Days of such date. The Cancellation Notice shall provide an irrevocable direction to deliver to
Parent (or its transfer agent) a number of Escrowed Shares equal to the difference between the aggregate number of Escrowed Shares deliverable pursuant to Section 6(b)(ii) above and the aggregate number of Escrowed Shares deliverable pursuant
to Section 6(b)(iii) above in accordance with Section 4.01(b)(ii) of the Merger Agreement, together with any dividends or other distributions or property paid or made in respect of such Escrowed Shares in the Escrow Fund relating thereto,
to be cancelled or, in the case of property other than capital stock of Parent, released to Parent. 
  

 5 

 (iii) If Dyloject Approval does not occur on or prior to June 30, 2011,
Parent shall provide the Escrow Agent and Stockholder Representative with a Cancellation Notice within two (2) Business Days of such date. The Cancellation Notice shall provide an irrevocable direction to deliver to Parent (or its transfer
agent) all Escrowed Shares, together with any dividends or other distributions or property paid or made in respect of such Escrowed Shares in the Escrow Fund relating thereto, to be cancelled or, in the case of property other than capital stock of
Parent, released to Parent. 
 (iv) Subject to the provisions of Section 6(d) hereof, within five
(5) Business Days of the receipt of a Cancellation Notice, the Escrow Agent shall deliver to Parent, the share certificates evidencing the Escrowed Shares to be cancelled (the “Cancelled Escrowed Shares”) pursuant to this
Section 6, as well as any dividends or distributions in the Escrow Fund relating thereto. The Cancelled Escrowed Shares shall be deemed to have been cancelled, and all rights of any Company Stockholder associated with the ownership of such
shares, including but not limited to the right to receive distributions, shall terminate, as of June 30, 2010, January 31, 2011 or June 30, 2011, as the case may be, regardless of when Parent receives the certificates
representing such shares. As of any such date, any Cancelled Escrowed Shares will cease to be shown as issued and outstanding on the books and records of Parent. 
 (d) If, within three (3) Business Days following receipt of any Release Notice or Cancellation Notice, the Stockholder Representative delivers a written notice to the Escrow Agent and Parent stating
its objection to the release or cancellation of Escrowed Shares and providing, in reasonable detail, the basis for such objection, the Escrow Agent shall not make any delivery of the Escrowed Shares, or any portion thereof, but shall retain such
shares until the Escrow Agent shall have either: (i) received joint written instructions signed by Parent and the Stockholder Representative; or (ii) been directed by a binding arbitration order or by an order of a court of competent
jurisdiction as to the respective rights of Parent, Stockholder Representative and the Company Stockholders with respect to the Escrowed Shares, in which case the Escrow Agent shall disburse the Escrowed Shares in accordance with such instructions
or order as soon as practicable after receipt thereof, unless such instructions or order otherwise provide. Notwithstanding anything to the contrary contained herein, if the Escrow Agent receives a joint written instruction from Parent and the
Stockholder Representative as to the disbursement of the Escrowed Shares, the Escrow Agent shall disburse the Escrowed Shares pursuant to such joint written instruction. 
 (e) The number of Escrowed Shares to be released from escrow or cancelled, as the case may be, in accordance with this Agreement shall be adjusted from time to time to account for any stock dividends,
stock splits, combinations or other similar recapitalizations affecting Parent Common Stock subsequent to the Merger Effective Time (each such change, a “Capital Change”). In the event that a Capital Change occurs subsequent to the
Merger Effective Time and prior to the termination of this Agreement pursuant to Section 8, Parent shall ensure

  

 6 

 
that the number of Escrowed Shares to be released from escrow or cancelled, as the case may be, in accordance with this Agreement takes into account the change in number of Escrowed Shares that
occurred as a result of such Capital Change and is adjusted, where necessary, such that the number of Escrowed Shares released from escrow or cancelled, as the case may be, in accordance with this Agreement is equal to that number of Escrowed Shares
that would be eligible for release or cancellation, as the case may be, had such Capital Change been given effect immediately prior to the Merger Effective Time. In the event of a Capital Change after the Merger Effective Time, Parent and the
Stockholder Representative will prepare a revised Schedule A making proportional adjustments to the numbers of Escrowed Shares thereon to appropriately reflect such Capital Change. 
 7. Transfer of Escrowed Shares. 
 (a) During the term of this Agreement, the interests of the Company Stockholders in the Escrowed Shares shall not be assignable or transferable, except by operation of law or the laws of descent and
distribution (and in either case the assignee or transferee shall be subject to the terms and conditions of this Agreement). During the term of this Agreement, the interest of Parent in the Escrowed Shares shall not be assignable or transferable,
except by operation of law (and assignee or transferee shall be subject to the terms and conditions of this Agreement). 
 (b)
Each certificate representing Escrowed Shares held in escrow shall have the following legend noted conspicuously thereon: 
 THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF THAT CERTAIN ESCROW AGREEMENT DATED [            ], 2010 BY AND AMONG MYRIAD PHARMACEUTICALS, INC., AMERICAN
STOCK TRANSFER AND TRUST COMPANY, AS ESCROW AGENT, AND FREDERICK E. PIERCE, II, AS STOCKHOLDER REPRESENTATIVE. THIS CERTIFICATE IS SUBJECT TO RESTRICTIONS ON TRANSFER UNTIL RELEASED FROM SUCH RESTRICTIONS IN ACCORDANCE WITH THE TERMS OF SUCH ESCROW
AGREEMENT. 
 (c) The Escrow Agent is hereby granted the power to effect any transfer of the interest of such Company
Stockholder in any Escrowed Shares permitted by this Agreement. Parent will cooperate (and cause its transfer agent to cooperate) with the Escrow Agent in promptly issuing stock certificates to effect such transfers (including the cancellation and
reissuance of the stock certificates representing cancelled and other Escrowed Shares). 
 8. Termination. This
Agreement shall terminate upon the earliest to occur of the following events: 
 (a) all Escrowed Shares have been either
released or cancelled in accordance with Section 6; 
  

 7 

 (b) Parent and the Stockholder Representative agree in writing to terminate this Agreement,
in which case the Escrow Agent shall distribute the Escrowed Shares in accordance with the joint written instructions of Parent and the Stockholder Representative; 
 (c) Dyloject Approval occurs prior to the Merger Effective Time; or 
 (d) upon
termination of the Merger Agreement prior to the Merger Effective Time. 
 9. Responsibilities and Liability of Escrow Agent.

 (a) Duties Limited. The Escrow Agent undertakes to perform only such duties as are expressly set forth herein. The
Escrow Agent may perform its duties through its agents and affiliates. The Escrow Agent’s duties shall be determined only with reference to this Agreement and applicable laws and it shall have no implied duties. The Escrow Agent shall not be
bound by, deemed to have knowledge of, or have any obligation to make inquiry into or consider, any term or provision of any agreement between Parent, Stockholder Representative, and/or any other third party which may be referred to herein or as to
which the escrow relationship created by this Agreement relates. 
 (b) Liability of Escrow Agent. Except in cases of the
Escrow Agent’s bad faith, willful misconduct or gross negligence, the Escrow Agent shall be fully protected (i) in acting in reliance upon any certificate, statement, request, notice, advice, instruction, direction, other agreement or
instrument or signature reasonably and in good faith believed by the Escrow Agent to be genuine, (ii) in assuming that any person purporting to give the Escrow Agent any of the foregoing in accordance with the provisions hereof, or in
connection with either this Agreement or the Escrow Agent’s duties hereunder, has been duly authorized to do so, and (iii) in acting or refraining from acting in good faith when advised to act or refrain to act, as the case may be, by any
counsel retained by the Escrow Agent. The Escrow Agent shall not be liable for any mistake of fact or law or any error of judgment, or for any act or omission, except as a result of its bad faith, willful misconduct or gross negligence. The Escrow
Agent shall not be responsible for any loss incurred upon any investment made under circumstances not constituting bad faith, willful misconduct or gross negligence. 
 Without limiting the generality of the foregoing, it is hereby agreed that in no event will the Escrow Agent and its agents and affiliates be liable for any lost profits or other indirect, special,
incidental or consequential damages which the parties may incur or experience by reason of having entered into or relied on this Agreement or arising out of or in connection with the Escrow Agent’s performance of services hereunder, even if the
Escrow Agent was advised or otherwise made aware of the possibility of such damages; nor shall the Escrow Agent be liable for acts of God, acts of war, breakdowns or malfunctions of machines or computers, interruptions or malfunctions of
communications or power supplies, labor difficulties, actions of public authorities, or any other similar cause or catastrophe beyond the Escrow Agent’s reasonable control. 
 In the event that the Escrow Agent shall be uncertain as to its duties or rights hereunder, or shall receive any certificate, statement,
request, notice, advice, instruction, direction or other

  

 8 

 
agreement or instrument from any other party with respect to the Escrow Fund which, in the Escrow Agent’s reasonable and good faith opinion, is in conflict with any of the provisions of this
Agreement, or shall be advised that a dispute has arisen with respect to the Escrow Fund or any part thereof, the Escrow Agent shall be entitled, without liability to any person, to refrain from taking any action other than to keep safely the Escrow
Fund until the Escrow Agent shall be directed otherwise in accordance with Section 6(d) hereof. The Escrow Agent shall be under no duty to institute or defend any legal proceedings, although the Escrow Agent may, in its discretion and at the
expense of Parent as provided in Sections 9(c) or 9(d) hereof, institute or defend such proceedings. 
 (c) Indemnification
of Escrow Agent. Parent agrees to indemnify the Escrow Agent and its officers, directors, employees, agents, affiliates, successors and assigns for, and to hold it harmless against, any and all claims, suits, actions, proceedings,
investigations, judgments, deficiencies, damages, settlements, liabilities and expenses (including reasonable legal fees and expenses of attorneys chosen by the Escrow Agent) as and when incurred, arising out of or based upon any act, omission,
alleged act or alleged omission by the Escrow Agent or its officers, directors, employees, agents, affiliates, successors and assigns or any other cause, in any case in connection with the acceptance of, or performance or non-performance by the
Escrow Agent of, any of the Escrow Agent’s duties under this Agreement, except as a result of the Escrow Agent’s bad faith, willful misconduct or gross negligence. 
 (d) Authority to Interplead. The parties hereto authorize the Escrow Agent, if the Escrow Agent is threatened with litigation or is
sued, to interplead all interested parties in any court of competent jurisdiction and to deposit the Escrow Fund with the clerk of that court. In the event of any dispute hereunder, the Escrow Agent shall be entitled to petition a court of competent
jurisdiction and shall perform any acts ordered by such court. 
 (e) No Representations. The Escrow Agent makes no
representations as to the validity, value, genuineness, or the collectibility of any security or other document or instrument held by or delivered to the Escrow Agent by or on behalf of the parties hereto. 
 10. Removal and Resignation of Escrow Agent. 
 (a) Removal. Parent and the Stockholder Representative acting together shall have the right to terminate the appointment of the Escrow Agent at any time by giving no less than thirty
(30) calendar days’ prior written notice of such termination to the Escrow Agent, specifying the date upon which such termination shall take effect. Thereafter, the Escrow Agent shall have no further obligation hereunder except to hold the
Escrow Fund as depositary. Parent and the Stockholder Representative agree that they will jointly appoint a banking corporation, trust company or other financial institution as successor Escrow Agent. The Escrow Agent shall refrain from taking any
action until it shall receive joint written instructions from Parent and the Stockholder Representative designating the successor Escrow Agent. The Escrow Agent shall deliver all of the Escrow Fund to such successor Escrow Agent in accordance with
such instructions and upon receipt of the Escrow Fund, the successor Escrow Agent shall be bound by all of the provisions hereof. 
  

 9 

 (b) Resignation. The Escrow Agent may resign and be discharged from its duties and
obligations hereunder at any time by giving no less than thirty (30) calendar days’ prior written notice of such resignation to Parent and the Stockholder Representative, specifying the date when such resignation will take effect.
Thereafter, the Escrow Agent shall have no further obligation hereunder except to hold the Escrow Fund as depository. In the event of such resignation, Parent and the Stockholder Representative agree that they will jointly appoint a banking
corporation, trust company, or other financial institution as successor Escrow Agent within thirty (30) calendar days of notice of such resignation. The Escrow Agent shall refrain from taking any action until it shall receive joint written
instructions from Parent and the Stockholder Representative designating the successor Escrow Agent. The Escrow Agent shall deliver all of the Escrow Fund to such successor Escrow Agent in accordance with such instructions and upon receipt of the
Escrow Fund, the successor Escrow Agent shall be bound by all of the provisions hereof. 
 11. General. 
 (a) Accounting. Upon each release or cancellation of any of the Escrowed Shares in the Escrow Fund or the termination of this
Agreement, the Escrow Agent shall render to Parent and the Stockholder Representative an accounting in writing of the Escrow Fund and all distributions therefrom. 
 (b) Survival. Notwithstanding anything herein to the contrary, the provisions of Sections 9(b) and 9(c) hereof shall survive any resignation or removal of the Escrow Agent, and any termination of
this Agreement. 
 (c) Escrow Agent Fees. The Escrow Agent shall charge a one-time administrative fee of $3,500.00, and
Parent shall be solely liable for the payment of such fee. 
 (d) Notices. All notices under this Agreement shall be
transmitted to the respective parties, shall be in writing and shall be considered to have been duly given or served when personally delivered to any individual party, or on the first (1st) Business Day after the date of deposit with an
overnight courier for next day delivery, postage paid, or on the third (3rd) Business Day after deposit in the United States Mail, certified or registered, return receipt requested, postage prepaid, or on the date of telecopy, fax or similar
telephonic transmission during normal business hours of the recipient, as evidenced by mechanical confirmation of such telecopy, fax or telephonic transmission; addressed in all cases to the party at his, her or its address set forth below, or to
such other address as such party may hereafter designate: 
 If to Parent: 
 Myriad Pharmaceuticals, Inc. 
 320 Wakara Way 
 Salt Lake City, UT 84108 
 Facsimile: 801-214-7992 
 E-Mail: adrian.hobden@myriadpharma.com 
 Attention: Adrian N.
Hobden, Ph.D. 
  

 10 

 Copies to: 
 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 
 One Financial Center 
 Boston, MA 02111 
 Facsimile: 617-542-2241 
 E-Mail: jlkravetz@mintz.com 
 Attention: Jonathan L. Kravetz, Esq. 
 If to the Stockholder
Representative: 
 Frederick E. Pierce, II 
 [                    ]

 [                    ] 
 Facsimile: [                    ] 
 E-Mail:
[                    ] 
 Attention: [                    ] 
 Copies to: 
 [                    ] 
 [                    ]

 [                    ] 
 Facsimile: [                    ] 
 E-Mail:
[                    ] 
 Attention: [                    ] 
 If to the Escrow Agent: 
 [                    ] 
 [                    ]

 [                    ] 
 Facsimile: [                    ] 
 E-Mail:
[                    ] 
 Attention: [                    ] 
 Any notice given hereunder may be given on behalf of any party by its counsel or other authorized representative. In all cases the Escrow Agent shall be entitled to rely on a copy or a fax transmission of
any document with the same legal effect as it were the original of such document. 
 (e) Modifications; Waiver. Subject
to the provisions of Section 6(a) and 6(e) regarding the completion and amendment of Schedule A, this Agreement may not be amended, altered or modified without the express prior written consent of each of the parties hereto.
Notwithstanding the preceding sentence, after the Effective Time, Schedule A may only be amended, altered or modified by the parties hereto pursuant to Section 6(e). No course of

  

 11 

 
conduct shall constitute a waiver of any terms or conditions of this Agreement, unless such waiver is specified in writing, and then only to the extent so specified. A waiver of any of the terms
and conditions of this Agreement on one occasion shall not constitute a waiver of the other terms of this Agreement, or of such terms and conditions on any other occasion. 
 (f) Further Assurances. If at any time the Escrow Agent shall consider or be advised that any further agreements, assurances or other
documents are reasonably necessary or desirable to carry out the provisions hereof and the transactions contemplated hereby, the parties hereto shall execute and deliver any and all such agreements or other documents, and do all things reasonably
necessary or appropriate to carry out fully the provisions hereof. 
 (g) Assignment. This Agreement shall inure to the
benefit of and be binding upon the successors, heirs, personal representatives, and permitted assigns of the parties hereto. This Agreement may not be assigned by the Escrow Agent, except that upon prior written notice to Parent and the Stockholder
Representative, the Escrow Agent may assign this Agreement to an affiliated or successor trust company or other qualified bank entity. 
 (h) Section Headings. The section headings contained in this Agreement are inserted for purposes of convenience of reference only and shall not affect the meaning or interpretation hereof. 
 (i) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without
regard to its rules of conflict of laws. Each of Parent, Stockholder Representative and Escrow Agent hereby irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the courts of the State of Delaware and of the United
States of America located in the State of Delaware (the “Delaware Courts”) for any litigation arising out of or relating to this Agreement and the transactions contemplated hereby (and agrees not to commence any litigation relating
thereto except in such courts), waives any objection to the laying of venue of any such litigation in the Delaware Courts, and agrees not to plead or claim in any Delaware Court that such litigation brought therein has been brought in any
inconvenient forum. Each of the parties hereto agrees, (a) to the extent such party is not otherwise subject to service of process in the State of Delaware, to appoint and maintain an agent in the State of Delaware as such party’s agent
for acceptance of legal process, and (b) that service of process may also be made on such party by prepaid certified mail with a proof of mailing receipt validated by United States Postal Service constituting evidence of valid service. Service
made pursuant to (a) or (b) above shall have the same legal force and effect as if served upon such party personally with the State of Delaware. 
 (j) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.

 [the next page is the signature page] 
  

 12 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. 
  

			
	MYRIAD PHARMACEUTICALS, INC.
		
	BY:	 	  

	NAME:	 	
	TITLE:	 	
	
	STOCKHOLDER REPRESENTATIVE
	
	  

	Frederick E. Pierce, II, solely in his capacity as Stockholder Representative
	
	AMERICAN STOCK TRANSFER AND TRUST COMPANY, as Escrow Agent
		
	BY:	 	  

	NAME:	 	
	TITLE:	 	

 [SIGNATURE PAGE TO ESCROW AGREEMENT] 

 Schedule A 
 [TO COME] 
  

 A-1Form of Javelin Stockholder Voting Agreement

 Exhibit 10.2 
 FORM OF VOTING AGREEMENT 
 FOR HOLDERS OF COMPANY
COMMON STOCK 
 THIS VOTING AGREEMENT (“Agreement”), dated as of December 18, 2009, is made by and
among Myriad Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Javelin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of
capital stock of the Company (the “Shares”). 
 WHEREAS, Parent, MPI Merger Sub, Inc., a Delaware corporation
and a wholly owned subsidiary of Parent (“Merger Sub”), and the Company have entered into an Agreement and Plan of Merger, dated of even date herewith (as such agreement may be subsequently amended or modified, the “Merger
Agreement”), providing for the merger of Merger Sub with and into the Company (the “Merger”); 
 WHEREAS, Stockholder beneficially owns and has sole voting power (or shares such power with Stockholder’s spouse) with respect to the number of Shares, and holds stock options or other rights to acquire the number of Shares, indicated
opposite Stockholder’s name on Schedule 1 attached hereto; 
 WHEREAS, as an inducement to, and a condition to the
willingness of, Parent and Merger Sub to enter into the Merger Agreement, and in consideration of the substantial expenses incurred and to be incurred by them in connection therewith, Stockholder has agreed to enter into and perform this Agreement;
and 
 WHEREAS, all capitalized terms used in this Agreement without definition herein shall have the meanings ascribed to them
in the Merger Agreement. 
 NOW, THEREFORE, in consideration of, and as a condition to, Parent and Merger Sub entering into the
Merger Agreement and proceeding with the transactions contemplated thereby, and in consideration of the expenses incurred and to be incurred by them in connection therewith, Stockholder, Parent and the Company agree as follows: 
 1. Agreement to Vote Shares. Stockholder agrees that, prior to the Expiration Date (as defined in Section 2 below), at any
meeting of the stockholders of the Company or any adjournment or postponement thereof, or in connection with any written consent of the stockholders of the Company, with respect to the Merger, the Merger Agreement or any Company Acquisition
Proposal, Stockholder shall: 
 (a) appear at such meeting or otherwise cause the Shares and any New Shares (as defined in
Section 3 below) to be counted as present thereat for purposes of calculating a quorum; 
 (b) from and after the date
hereof until the Expiration Date, vote (or cause to be voted) or deliver a written consent (or cause a written consent to be delivered) covering all of the Shares and any New Shares that Stockholder shall be entitled to so vote: (i) in favor of
adoption and approval of the Merger Agreement and all other transactions contemplated by the Merger Agreement and any matter necessary for consummation of the Merger as to which stockholders of the Company are called upon to vote in favor of or
consent to and (ii) against any Company Acquisition Proposal. Stockholder shall not take or commit or agree to take any action inconsistent with the foregoing. 

 2. Expiration Date. As used in this Agreement, the term “Expiration
Date” shall mean the earlier to occur of (a) the Merger Effective Time, (b) such date and time as the Merger Agreement shall be terminated pursuant to Article X thereof or otherwise, or (c) upon mutual written agreement of
each of the parties to terminate this Agreement. This Agreement shall automatically terminate upon the Expiration Date. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this
Agreement; provided, however, such termination or expiration shall not relieve any party from liability for any willful breach of this Agreement or acts of bad faith prior to termination hereof. 
 3. Additional Purchases. Stockholder agrees that any shares of capital stock or other equity securities of the Company that
Stockholder purchases or with respect to which Stockholder otherwise acquires sole voting power (or shared voting power with Stockholder’s spouse) after the execution of this Agreement and prior to the record date for determining the Company
stockholders entitled to vote with respect to the Merger, whether by the exercise of any stock options or otherwise (“New Shares”), shall be subject to the terms and conditions of this Agreement to the same extent as if they
constituted the Shares. 
 4. Agreement to Retain Shares. From and after the date hereof until the Expiration Date,
Stockholder shall not, directly or indirectly, knowingly take any action that would make any representation or warranty of Stockholder contained herein untrue or incorrect in any material respect or have the effect of preventing or disabling
Stockholder from performing Stockholder’s obligations under this Agreement. Notwithstanding the foregoing, Stockholder may make transfers of Shares (a) by will or by operation of law or other transfers for estate-planning purposes, in
which case this Agreement shall bind all transferees, and (b) as Parent may otherwise agree in writing in its sole discretion. Notwithstanding anything contained herein to the contrary, nothing in this Agreement shall prohibit or prevent the
cashless exercise of any Company Stock Options by Stockholder. 
 5. Representations and Warranties of Stockholder.
Stockholder hereby represents and warrants to Parent and the Company as follows: 
 (a) Stockholder has the full power and
authority to execute and deliver this Agreement and to perform Stockholder’s obligations hereunder; 
 (b) this Agreement
has been duly executed and delivered by or on behalf of Stockholder and, to Stockholder’s knowledge and assuming this Agreement constitutes a valid and binding agreement of Parent and the Company, constitutes a valid and binding agreement with
respect to Stockholder, enforceable against Stockholder in accordance with its terms, except as enforcement may be limited by general principles of equity whether applied in a court of law or a court of equity and by bankruptcy, insolvency and
similar laws affecting creditors’ rights and remedies generally; 
 (c) except as set forth on Schedule 1,
Stockholder beneficially owns the number of Shares indicated opposite Stockholder’s name on Schedule 1, and will own any New

  

 2 

 
Shares, free and clear of any liens, claims, security interests, pledges or other encumbrances or restrictions of any kind or nature whatsoever (“Liens”) except for any
restrictions under applicable securities laws, and has sole, and otherwise unrestricted, voting power with respect to such Shares or New Shares and none of the Shares or New Shares is subject to any voting trust or other agreement, arrangement or
restriction with respect to the voting of the Shares or the New Shares, except as contemplated by this Agreement; 
 (d) to the
knowledge of Stockholder, the execution and delivery of this Agreement by Stockholder does not, and the performance by Stockholder of his or her obligations hereunder and the compliance by Stockholder with any provisions hereof will not, violate or
conflict with, result in a material breach of or constitute a material default (or an event that with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of any Liens on any Shares or New Shares pursuant to, any agreement, instrument, note, bond, mortgage, contract, lease, license, permit or other obligation or any order, arbitration award, judgment or
decree to which Stockholder is a party or by which Stockholder is bound, or any law, statute, rule or regulation to which Stockholder is subject or, in the event that Stockholder is a corporation, partnership, trust or other entity, any bylaw or
other organizational document of Stockholder; and 
 (e) to the knowledge of Stockholder, the execution and delivery of this
Agreement by Stockholder does not, and the performance of this Agreement by Stockholder does not and will not, require any consent, approval, authorization or permit of, or filing with or notification to, any governmental or regulatory authority by
Stockholder except for applicable requirements, if any, of the Exchange Act, and except where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not prevent or delay the
performance by Stockholder of his or her obligations under this Agreement in any material respect. 
 6. Irrevocable
Proxy. Subject to the last sentence of this Section 6, by execution of this Agreement, Stockholder does hereby appoint Adrian N. Hobden, Ph.D., President and Chief Executive Officer of Parent, Robert J. Lollini, Chief Financial Officer of
Parent, and Andrew Gibbs, Secretary of Parent, and each of them, with full power of substitution and resubstitution, as Stockholder’s true and lawful attorney and proxy, to the fullest extent of the undersigned’s rights with respect to the
Shares, to vote, if Stockholder is unable to perform his or her obligations under this Agreement, each of the Shares and New Shares solely with respect to the matters set forth in Section 1 hereof. Stockholder intends this proxy to be
irrevocable and coupled with an interest hereunder until the Expiration Date in accordance with the provisions of Section 212 of the DGCL and hereby revokes any proxy previously granted by Stockholder with respect to the Shares and represents
that none of such previously granted proxies are irrevocable. Notwithstanding anything contained herein to the contrary, this irrevocable proxy shall automatically terminate upon the Expiration Date of this Agreement. 
 7. No Solicitation. From and after the date hereof until the Expiration Date, Stockholder, insofar as Stockholder is acting in his,
her or its capacity as a stockholder of the Company, shall not (a) initiate, solicit, seek or knowingly encourage or support any inquiries, proposals or offers that constitute or may reasonably be expected to lead to, a Company

  

 3 

 
Acquisition Proposal, (b) engage or participate in, or knowingly facilitate, any discussions or negotiations regarding, or furnish any nonpublic information to any Person in connection with,
any inquiries, proposals or offers that constitute, or may reasonably be expected to lead to, a Company Acquisition Proposal, (c) enter into any letter of intent, agreement in principle or other similar type of agreement relating to a Company
Acquisition Proposal, or enter into any agreement or agreement in principle requiring the Company to abandon, terminate or fail to consummate the transactions contemplated by the Merger Agreement, (d) initiate a stockholders’ vote or
action by consent of the Company’s stockholders with respect to a Company Acquisition Proposal, (e) except by reason of this Agreement, become a member of a “group” (within the meaning of Section 13(d) of the Exchange Act)
with respect to any voting securities of the Company that takes any action in support of a Company Acquisition Proposal or (f) propose or agree to do any of the foregoing. In the event that Stockholder is a corporation, partnership, trust or
other entity, it shall not permit any of its Subsidiaries or Affiliates to, nor shall it authorize any officer, director or representative of Stockholder, or any of its Subsidiaries or Affiliates to, undertake any of the actions contemplated by this
Section 7. Nothing in this Section 7 shall restrict any actions permitted under the Merger Agreement by Stockholder in his or her capacity as an officer or director of the Company. 
 8. Fiduciary Responsibilities. Stockholder makes no agreement or understanding herein in his or her capacity as a director or officer
of the Company. Without limiting the generality of the foregoing, Stockholder (or a designee of Stockholder) signs solely in his or her capacity as the record and beneficial owner of Stockholder’s Shares and nothing herein shall limit or affect
any actions taken by Stockholder (or a designee of Stockholder) in his or her capacity as an officer or director of the Company in exercising his or her or the Company’s or the Company’s Board of Directors’ rights in connection with
the Merger Agreement or otherwise and such actions shall not be deemed to be a breach of this Agreement. 
 9. Specific
Enforcement. The parties hereto agree that irreparable damage would occur in the event any provision of this Agreement was not performed in accordance with the terms hereof or was otherwise breached. It is accordingly agreed that the parties
shall be entitled to seek specific relief hereunder, including, without limitation, an injunction or injunctions to prevent and enjoin breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof, in any
state or federal court in any competent jurisdiction, in addition to any other remedy to which they may be entitled at law or in equity. Any requirements for the securing or posting of any bond with respect to any such remedy are hereby waived.

 10. Further Assurances. Stockholder shall, from time to time, execute and deliver, or cause to be executed and
delivered, such additional or further consents, documents and other instruments as Parent or the Company may reasonably request for the purpose of effectively carrying out the transactions contemplated by this Agreement and the Merger Agreement.

 11. Disclosure. Stockholder hereby agrees that Parent and the Company may publish and disclose in the Registration
Statement (including all documents and schedules filed with the SEC), the Joint Proxy Statement, any Current Report on Form 8-K required to be filed in connection with the Merger, any filing with any regulatory authority in connection with the
Merger and any related documents filed with such regulatory authority and as otherwise required

  

 4 

 
by Law, Stockholder’s identity and ownership of Shares and New Shares and the nature of Stockholder’s commitments, arrangements and understandings under this Agreement and may further
file this Agreement as an exhibit to the Registration Statement or prospectus or in any other filing made by Parent or the Company as required by Law or the terms of the Merger Agreement, including with the SEC or other regulatory authority,
relating to the Merger, all subject to prior review and an opportunity to comment by Parent’s and the Company’s counsel. 
 12. Notice. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or sent by nationally-recognized overnight courier (providing proof of delivery) or by electronic mail
(providing a copy to be delivered by mail) or by facsimile transmission (providing confirmation of transmission) to Parent or the Company, as the case may be, in accordance with Section 12.02 of the Merger Agreement and to Stockholder at its
address set forth on Schedule 1 attached hereto (or at such other address for a party as shall be specified by like notice). 
 13. Severability. If any term or other provision of this Agreement is determined to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision
is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law
in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible. 
 14.
Binding Effect and Assignment. All of the covenants and agreements contained in this Agreement shall be binding upon, and inure to the benefit of, the respective parties and their permitted successors, assigns, heirs, executors,
administrators and other legal representatives, as the case may be. Except as otherwise set forth in this Section 14, this Agreement may not be assigned by any party hereto without the prior written consent of the other parties hereto.

 15. No Third Party Beneficiaries. This Agreement is not intended, and shall not be deemed, to confer any rights or
remedies upon any person other than the parties hereto and their respective successors and permitted assigns, to create any agreement of employment with any person or to otherwise create any third-party beneficiary hereto. 
 16. No Waivers. No waivers of any breach of this Agreement extended by Parent or the Company to Stockholder shall be construed as a
waiver of any rights or remedies of Parent or the Company, as applicable, with respect to any other stockholder of the Company who has executed an agreement substantially in the form of this Agreement, with respect to Shares held or subsequently
held by such stockholder or with respect to any subsequent breach of Stockholder or any other such stockholder of the Company. No waiver of any provisions hereof by any party shall be deemed a waiver of any other provisions hereof by any such party,
nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. 
  

 5 

 17. Governing Law; Jurisdiction and Venue. THIS AGREEMENT IS MADE UNDER, AND SHALL BE
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS OF LAW. In any action between or among any of the parties, whether arising out of this Agreement or otherwise,
(a) each of the parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the state and federal courts located in New Castle County, Delaware; (b) if any such action is commended in a state
court, then, subject to applicable law, no party shall object to the removal of such action to any federal court located in New Castle County, Delaware; (c) each of the parties irrevocably waives the right to trial by jury; and (d) each of
the parties irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepared, to the address at which such party is to receive notice in accordance with Section 12. 
 18. Waiver of Jury Trial. The parties hereto hereby waive any right to trial by jury with respect to any action or proceeding related
to or arising out of this Agreement, any document executed in connection herewith and the matters contemplated hereby and thereby. 
 19. No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or
understanding between the parties hereto unless and until (a) the Board of Directors of the Company has approved, for purposes of any applicable anti-takeover laws and regulations and any applicable provision of the Company’s Certificate
of Incorporation, the transactions contemplated by the Merger Agreement, (b) the Merger Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto. 
 20. Entire Agreement; Amendment. This Agreement supersedes all prior agreements, written or oral, among the parties hereto with
respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be amended, supplemented or modified, and no provisions hereof may be modified or waived,
except by an instrument in writing signed by each party hereto. 
 21. Effect of Headings. The section headings herein
are for convenience only and shall not affect the construction or interpretation of this Agreement. 
 22. Counterparts.
This Agreement may be executed and delivered, including by facsimile transmission, in one or more counterparts, each of which will be deemed an original but all of which together shall constitute one and the same instrument. 
  

 6 

 EXECUTED as of the date first above written. 
  

			
	STOCKHOLDER
	
	  

	 Name:
	 	
	
	MYRIAD PHARMACEUTICALS, INC.
		
	 By:
	 	  

	 Name:
	 	Adrian N. Hobden
	 Title:
	 	President and Chief Executive Officer
	
	JAVELIN PHARMACEUTICALS, INC.
		
	 By:
	 	  

	 Name:
	 	Martin J. Driscoll
	 Title:
	 	Chief Executive Officer

 Schedule of Signatories 
  

	•	 	 Martin J. Driscoll 

  

	•	 	 Jackie M. Clegg 

  

	•	 	 Neil W. Flanzraich 

  

	•	 	 Peter D. Kiernan, III 

  

	•	 	 Fred H. Mermelstein 

  

	•	 	 Georg Nebgen 

  

	•	 	 Douglas G. Watson 

  

	•	 	 Stephen J. Tulipano 

  

	•	 	 Daniel B. Carr

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]